Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma
Illidge, T, Chan, C, Counsell, N, Morris, S, Scarisbrick, J, Gilson, D, Popova, B, Patrick, P, Smith, P, Whittaker, S, Cowan, RVolume:
109
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2013.616
Date:
November, 2013
File:
PDF, 588 KB
english, 2013